|
||||||||
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Neoadjuvant Therapy
ACOSOG-Z1031
American College of Surgeons Oncology Group
Matthew Ellis MD, PhD, FRCP, Protocol Chair
Tel: 314-362-8866
American College of Surgeons Oncology Group
John Olson, MD, PhD, Protocol Co-chair
Tel: 919-684-6523
Email: jaomd@duke.edu
Cancer and Leukemia Group B
Kevin Hughes, MD, FACS, Principal Investigator
Tel: 617-724-4800
Email: kshughes@partners.org
Radiation Therapy
NSABP-B-39
National Surgical Adjuvant Breast
and Bowel Project
Frank Vicini, MD, FACR, Protocol Chair
Tel: 248-551-1219; 800-633-7377
Douglas Arthur, MD, Protocol Co-chair
Tel: 804-828-7232
Email: darthur@mcvh-vcu.edu
Robert Kuske, MD, Protocol Co-chair
Tel: 608-263-8500; 800-622-8922
Email: kuske@mail.humonc.wisc.edu
Radiation Therapy Oncology Group
Julia White, MD, Protocol Chair
Tel: 414-805-4462
Email: jwhite@radonc.mcw.edu
Rachel Rabinovitch, MD, Protocol Co-chair
Tel: 720-848-0116; 800-473-2288
Email: rachel.rabinovitch@uchsc.edu
Southwest Oncology Group
Lori Pierce, MD, Protocol Chair
Tel: 734-936-7810; 800-865-1125
Adjuvant Endocrine Therapy
IBIS-II, IBIS-IIB (DCIS)
Cancer Research UK at Imperial College
School of Medicine — London
Jack Cuzick, PhD, Study Coordinator
Tel: 44-20-7269-3006
International Breast Cancer Study Group
Katharina Buser, MD, Protocol Chair
Tel: 41-31-309-9501
Email: kbuser@sonnenhof.ch
NSABP-B-42
National Surgical Adjuvant Breast
and Bowel Project
Eleftherios Mamounas, MD, MPH, FACS
Protocol Chair
Tel: 412-330-4600; 330-438-6281
Email: tmamounas@aultman.com
CAN-NCIC-MA27/CFEM345D2411
Novartis Pharmaceuticals Corporation
Novartis Study Chair
Tel: 41-61-324-1111
NCIC-Clinical Trials Group
Paul Goss, MD, PhD, Protocol Chair
Tel: 617-724-3118; 877-726-5130
North Central Cancer Treatment Group
James Ingle, MD, Protocol Chair
Tel: 507-284-8432
Email: ingle.james@mayo.edu
Cancer and Leukemia Group B
Matthew Ellis, MD, PhD, FRCP Protocol Chair
Tel: 314-362-8903; 800-600-3606
Eastern Cooperative Oncology Group
George Sledge, MD, Protocol Chair
Tel: 317-274-0920; 888-600-4822
Email: gsledge@iupui.edu
Southwest Oncology Group
George Budd, MD, Protocol Chair
Tel: 216-444-6480; 800-862-7798
International Breast Cancer Study Group
Manuela Rabaglio, MD, Principal Investigator
Tel: 41-31-632-4370
Email: manuela.rabaglio@insel.ch
SOFT/TEXT/PERCHE
International Breast Cancer Study Group
Prudence Francis, MD, Protocol Chair
Tel: 61-39-656-1701
Email: Prue.Francis@petermac.org
Breast International Group
Prudence Francis, MD, Protocol Chair
Tel: 61-39-656-1701
Email: Prue.Francis@petermac.org
Cancer and Leukemia Group B
Gini Fleming, MD, Protocol Chair
Tel: 773-702-6712; 888-824-0200
Email: gfleming@medicine.bsd.uchicago.edu
TEXT
International Breast Cancer Study Group
Olivia Pagani, MD, Protocol Chair
Tel: 41-91-811-3667
Breast International Group
Olivia Pagani, MD, Protocol Chair
Tel: 41-91-811-3667
Prudence Francis, MD, Protocol Chair
Tel: 61-39-656-1701
PERCHE
International Breast Cancer Study Group
Rosalba Torrisi, MD, Protocol Chair
Tel: 39-02-5748-9482
Breast International Group
Rosalba Torrisi, MD, Protocol Chair
Tel: 39-02-5748-9482
Adjuvant Chemotherapy
SWOG-S0307
Southwest Oncology Group
Julie Gralow, MD, Study Coordinator
Tel: 507-284-2511
Email: pink@u.washington.edu
Robert Livingston, MD, Study Coordinator
Tel: 206-288-1085
North Central Cancer Treatment Group
James Ingle, MD, Study Coordinator
Tel: 507-284-2511
Email: ingle.james@mayo.edu
Eastern Cooperative Oncology Group
Carla Falkson, MD, Study Coordinator
Tel: 205-975-2691
Email: cfalkson@uab.edu
National Surgical Adjuvant Breast and Bowel Project
Alexander Paterson, MD, FRCP, FACP, MBChB,
Study Coordinator
Tel: 403-521-3688
Email: alexpate@cancerboard.ab.ca
Cancer and Leukemia Group B
Elizabeth Dees, MD, Study Coordinator
Tel: 919-843-7714
NCIC-Clinical Trials Group
Mark Clemons, MD, Study Coordinator
Tel: 416-480-5847
Email: mark.clemons@sw.ca
TAILORx
Eastern Cooperative Oncology Group
Joseph Sparano, MD, Protocol Chair
Tel: 718-920-4826
Email: jsparano@montefiore.org
Southwest Oncology Group
Daniel Hayes, MD, Protocol Chair
Tel: 734-615-6725; 800-865-1125
Email: hayesdf@umich.edu
Cancer and Leukemia Group B
Elizabeth Dees, MD, Protocol Chair
Tel: 919-966-4431
American College of Surgeons Oncology Group
John Olson, MD, PhD, Protocol Chair
Tel: 919-668-1767; 888-275-3853
Email: jaomd@duke.edu
North Central Cancer Treatment Group
Edith Perez, MD, Protocol Chair
Tel: 904-953-7283
Email: perez.edith@mayo.edu
NCIC Clinical Trials Group
Kathleen Pritchard, MD, Protocol Chair
Tel: 416-480-4616
Email: kathy.pritchard@sw.ca
National Surgical Adjuvant Breast
and Bowel Project
Charles Geyer, FACP, MD, Protocol Chair
Tel: 412-359-8353; 866-680-0004
CALGB-49907
Eastern Cooperative Oncology Group
Hyman Muss, MD, Protocol Chair
Tel: 802-847-3827; 800-358-1144
Eastern Cooperative Oncology Group
Antonio Wolff, MD, Protocol Chair
Tel: 410-614-4192
Email: awolff@jhmi.edu
Southwest Oncology Group
Julie Gralow, MD, Protocol Chair
Email: pink@u.washington.edu
NCIC-Clinical Trials Group
Debjani Grenier, MD, Protocol Chair
CALGB-40101/NSABP-B-36
Cancer and Leukemia Group B
Lawrence Shulman, MD, Protocol Chair
Tel: 617-632-2277; 866-790-4500
Email: Lawrence_Shulman@dfci.harvard.edu
National Surgical Adjuvant Breast and
Bowel Project
Richard Elledge, MD, Protocol Chair
Tel: 713-798-1655
Email: relledge@bcm.tmc.edu
SWOG-S0221
Southwest Oncology Group
George Budd, MD, Study Coordinator
Tel: 216-444-6480; 800-862-7798
Email: S0221@cc.ccf.org
Halle Moore, MD, Study Coordinator
Tel: 216-445-4624; 800-862-7798
NSABP-B-38
National Surgical Adjuvant Breast
and Bowel Project
Sandra Swain, MD, Protocol Chair
Tel: 301-496-0901
ECOG-E2104
Eastern Cooperative Oncology Group
Kathy Miller, MD, Protocol Chair
Tel: 317-274-0920; 888-600-4822
Email: kathmill@iupui.edu
Robin Zon, MD, Protocol Co-chair
Tel: 574-234-5123
North Central Cancer Treatment Group
Edith Perez, MD, Protocol Chair
Tel: 507-284-1159
Email: perez.edith@mayo.edu
NCT00121134
Dana-Farber/Harvard Cancer Center at
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Harold Burstein, MD, PhD, Principal Investigator
Tel: 617-632-6767
Metastatic Disease
SoFEA
Institute of Cancer Research — Sutton
Stephen Johnston, MD, PhD, FRCP
Protocol Chair
Tel: 44-20-7808-2745
Email: stephen.johnston@rmh.nhs.uk
SWOG-S0226
Southwest Oncology Group
Rita Mehta, MD, Study Coordinator
Tel: 714-456-5153
NCIC-Clinical Trials Group
Theodore Vandenberg, MD, Protocol Chair
Tel: 519-685-8640
FACT
AstraZeneca Pharmaceuticals LP
Roger Henriksson, MD, Study Director
AstraZeneca Clinical Study Information
Tel: 46-(0)8-553-26000
CONFIRM TRIAL
AstraZeneca Pharmaceuticals LP
AstraZeneca Cancer Support Network
Tel: 866-992-9276
EGF104383
GSK Clinical Trials
See the NCI Physician Data Query at
cancer.gov/search/clinical_trials/
for participating sites
EGF104900
GSK Clinical Trials
See the NCI Physician Data Query at
cancer.gov/search/clinical_trials/
for participating sites
CALGB-40503
Cancer and Leukemia Group B
Maura N Dickler, MD, Principal Investigator
Matthew J Ellis, MD, PhD, Principal Investigator
UCLA-0502057-01
Jonsson Comprehensive Cancer Center at UCLA
Richard Pietras, MD, PhD, Protocol Chair
Tel: 310-825-9769, 888-798-0719
Email: rpietras@ucla.edu
RIBBON 1/RIBBON 2
Ribbon 1: Genentech Incorporated
Barbara J Hencke, MD, Study Director
Genentech Trial Information Support Line
Tel: 888-662-6728
Ribbon 2: Genentech Incorporated
Julie Hambleton, MD, Study Director
Genentech Trial Information Support Line
Tel: 888-662-6728
 |
 |
Editor’s Note:
Let’s get this thing done.
Prologue:
The adjuvant trastuzumab clinical research to
practice model
- Select publications
Breast Cancer Clinical Trials:
Neoadjuvant Therapy
 |
 |
 |
 |
 |
